Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Michael Werner

Advertisement
Set Alert for Articles By Michael Werner

Latest From Michael Werner

New Payment And Financing Models For Curative Regenerative Medicines

Cell and gene therapies that have the potential to cure require new approaches to value assessment, payment and financing. In the second of a series, the Alliance for Regenerative Medicine identifies potential payment models, highlights key stakeholder concerns and identifies the barriers that must be addressed to enable their integration across the health care system.

BioPharmaceutical Pricing Strategies

About ARM

The Alliance for Regenerative Medicine is partnering with representatives from other organizations engaged in multi-stakeholder initiatives to prepare the health care system for curative and/or regenerative medicines.

BioPharmaceutical

Curative Regenerative Medicines: Preparing Health Care Systems For The Coming Wave

We may be at the dawn of a new era of curative regenerative therapies, but their inherent nature may create barriers to adoption. The Alliance for Regenerative Medicine frames the opportunities and challenges for the industry, arguing that policy makers must begin to understand the ways that these therapies represent value for money.

Regenerative Medicine BioPharmaceutical
See All
Advertisement
UsernamePublicRestriction

Register